Feline Atopic Dermatitis Treatment Market

Report Highlights

Feline atopic dermatitis is the inflammation of the skin seen in the cats. Feline atopic dermatitis is often triggered by causative allergens which are either inhaled or through skin contact leading to inflammation of the skin. As per the study carried out by the Canadian Veterinary Journal the conservative prevalence of the feline atopic dermatitis in the cats is around 12.5% whereas the actual prevalence is high as it is very common disorder in cats. The diagnosis of the often starts when itchy skin is observed in the cats.

The feline atopic dermatitis treatment often involves the medications which help to decrease the immune response which causes pruritus. Various non-inflammatory drugs are also used in the feline atopic dermatitis treatment. Most often the feline atopic dermatitis is lifelong condition of inflamed skin, it may be seasonal or non-seasonal which leads to frequent visits to veterinarians for feline atopic dermatitis treatment.

Feline Atopic Dermatitis Treatment Market: Drivers and Restraints

High prevalence of atopic dermatitis among the cats irrespective of the region expected to drive the growth of the feline atopic dermatitis treatment market. Around 62.0% of U.S. households have one or more companion animals and it is expected to increase rapidly which in turn expected to drive the growth of the feline atopic dermatitis treatment market. Increasing trend of companion animals in regions such as Asia-Pacific and Latin America further expected to fuel the growth of the feline atopic dermatitis treatment market.

Increasing diagnosis and subsequently increasing treatment seeking rate for various diseases in companion animals further expected to drive the growth of the feline atopic dermatitis treatment market. Increasing number of companion animals coupled with increasing number of veterinarians in the developing countries expected to drive the growth of the feline atopic dermatitis treatment market. Whereas, lack of novel treatment which can prevent the reoccurrence of the atopic dermatitis may hamper the growth of the feline atopic dermatitis treatment market.

Feline Atopic Dermatitis Treatment Market: Segmentation

The global feline atopic dermatitis treatment market is segmented on the basis of the drug class, route of administration, distribution channel and region

By drug class, the global feline atopic dermatitis treatment market is segmented as:

• Corticosteroids
• Antihistamines
• Antibiotics

By route of administration, the global feline atopic dermatitis treatment market is segmented as:

• Oral
• Topical
• Injectable

By distribution channel, the global feline atopic dermatitis treatment market is segmented as:

• Veterinary Pharmacies
• Retail Pharmacies
• Online Pharmacies

Feline Atopic Dermatitis Treatment Market: Overview

The global feline atopic dermatitis treatment market is expected to experience significant growth due to increasing prevalence of the feline atopic dermatitis. By drug class, corticosteroids is expected to dominate the global feline atopic dermatitis treatment market by revenue due to higher efficacy as compared to other drug classes. By route of administration, feline atopic dermatitis treatment market is expected to be dominated by topical segment due to higher compliance. By distribution channel, feline atopic dermatitis treatment market is expected to be dominated by veterinary pharmacies due to higher footfall.

Feline Atopic Dermatitis Treatment Market: Regional Outlook

North America expected to dominate the global feline atopic dermatitis treatment market due to higher number of companion animals in the region. Europe feline atopic dermatitis treatment market due to increasing number of companion animals as well as higher treatment seeking rate as compared to other developing regions. Asia-Pacific is emerging feline atopic dermatitis treatment market due to rapidly increasing companion animal ownership and emerging countries such as India and China. Latin America is expected to experience gradual growth in the feline atopic dermatitis treatment market due to increasing product availability in the region. Middle East & Africa feline atopic dermatitis treatment market is expected to be least lucrative market due to least adoption of feline atopic dermatitis treatment.

Feline Atopic Dermatitis Treatment Market: Key Players

The key market players operating in the feline atopic dermatitis treatment market are: Bausch Health Companies Inc., Bayer AG, Pfizer Inc., Novartis AG, Eli Lily Company, Sanofi, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Indication
• Value Chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.